IP Library Patent Application 14839749
Patent Application
App. No. 14/839,749

SYSTEMS AND METHODS FOR MULTI-ANALYSIS

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
14/839,749
Abstract

Systems and methods are provided for sample processing. A device may be provided, capable of receiving the sample, and performing one or more of a sample preparation, sample assay, and detection step. The device may be capable of performing multiple assays. The device may comprise one or more modules that may be capable of performing one or more of a sample preparation, sample assay, and detection step. The device may be capable of performing the steps using a small volume of sample.

Claims (41)

1 - 8 . (canceled)

9 . A device for analyzing a sample having a volume of less than about 250 microliters (μL), said device being configured to perform two or more assays selected from an immunoassay, a nucleic acid assay, and a receptor-based assay on said sample, the device comprising:

a housing containing a plurality of stations and systems, said plurality of stations and systems comprising:

a sample handling system comprising a fluid handling system comprising a pipette and configured to transport a sample having a volume of less than about 250 μL, or a portion thereof, within said housing;

a sample preparation station configured to perform a plurality of sample preparation procedures on the sample, or on a portion thereof, said sample preparation procedures consisting of sample processing, magnetic separation and chemical processing;

an assay station configured to perform an immunoassay, a nucleic acid assay, and a receptor-based assay on the sample, or on a portion thereof, wherein each assay is configured to yield a detectable optical signal; and

a detection station comprising at least one optical sensor, said sensor being configured to detect an optical signal yielded by an assay.

10 . The device of claim 9 , further comprising a cytometry station configured to perform a cytometry assay by microscopy on stationary cells in a sample portion, wherein said sample portion is fluidically isolated from other portions of said sample.

11 . The device of claim 10 , configured to perform three or more assays on a single sample having a volume of less than about 250 μL, or on portions thereof, wherein said three or more assays are selected from an immunoassay, a nucleic acid assay, a receptor-based assay, and a cytometry assay.

12 . The device of claim 10 , configured to perform each of an immunoassay, a nucleic acid assay, a receptor-based assay, and a cytometry assay on a single sample having a volume of less than about 250 μL, or on portions thereof.

13 . The device of claim 9 , wherein said sample preparation station comprises a centrifuge, and is configured to perform centrifugation.

14 . The device of claim 9 , wherein said sample handling system is configured to transport one or more individually addressable assay units to said assay station.

15 . The device of claim 9 , wherein said assay station is configured to receive one or more individually addressable assay units, each assay unit being fluidically isolated from one another, wherein at least one type of assay may be performed within said individually addressable assay unit effective to yield an optical signal.

16 . The device of claim 9 , wherein said sample handling system is configured to transport one or more individually addressable assay units from said assay station to said detection station for detection of said detectable optical signal yielded by performance of an assay.

17 . The device of claim 10 , wherein said sample handling system is configured to move an individually addressable assay unit from said assay station to the cytometry station.

18 . The device of claim 9 , said assay station being configured to receive one or more individually addressable assay units, each assay unit being fluidically isolated from one another, wherein a given type of assay performed within said individually addressable assay unit is configured to yield a detectable signal.

19 . The device of claim 9 , wherein said detection station comprises an optical detector for one or more of spectrophotometry, fluorimetry, luminometry, turbidimetry, nephelometry, refractometry, and polarimetry.

20 . The device of claim 10 , wherein said stationary cells are contained in a microscopy cuvette or slide configured to contain said stationary cells.

21 . The device of claim 9 , wherein said assay station is configured to perform an agglutination assay.

22 . The device of claim 18 , wherein said pipette is configured to uptake, dispense, or transfer said biological sample, or combinations thereof.

23 . The device of claim 18 , wherein said fluid handling system is configured to transport an individual assay unit within said housing.

24 . The device of claim 9 , further comprising a communication unit configured to receive instructions from an external device.

25 . The device of claim 9 , further comprising a communication unit configured to send data to an external device.

26 . The device of claim 9 , further comprising a communication unit configured to perform two-way communication with external devices, said communication unit being configured to a) receive instructions from an external device, and b) to send data to an external device.

27 . The device of claim 24 which is configured to communicate with a Laboratory Information System (LIS), a Laboratory Information System (LIS), a Electronic Medical Records system (EMR), or combinations thereof.

28 . The device of claim 9 which is a benchtop device.

29 . The device of claim 9 , wherein said sample has a volume of less than about 200 microliters (μL).

30 . The device of claim 9 , wherein said sample has a volume of less than about 100 microliters (μL).

31 . The device of claim 9 , wherein said sample is a biological sample selected from blood, serum, saliva, urine, gastric fluid, digestive fluid, tears, stool, semen, vaginal fluid, interstitial fluid, fluid derived from tumorous tissue, ocular fluid, sweat, mucus, earwax, oil, glandular secretions, breath, spinal fluid, hair, fingernails, skin cells, plasma, fluid obtained from a nasal swab, fluid obtained from a nasopharyngeal wash, cerebrospinal fluid, a tissue sample, fluid or tissue obtained from a throat swab, biopsy tissue, placental fluid, amniotic fluid, cord blood, lymphatic fluids, cavity fluids, sputum, pus, microbiota, meconium, and breast milk.

32 . A method of analyzing a sample, comprising:

Receiving a sample having a volume of less than about 250 microliters (μL) by a device of claim 9 ;

Performing at least two of an immunoassay, a nucleic acid assay, and a receptor-based assay on said sample.

33 . The method of claim 32 , comprising performing an immunoassay, a nucleic acid assay, and a receptor-based assay on said sample.

34 . A method of analyzing a sample, comprising:

Receiving a sample having a volume of less than about 250 microliters (μL) by a device of claim 10 ;

Performing at least two of an immunoassay, a nucleic acid assay, and a receptor-based assay on said sample; and

Performing a cytometry assay by microscopy on stationary cells in a sample portion, wherein said sample portion is fluidically isolated from other portions of said sample.

35 . The method of claim 34 , comprising performing an immunoassay, a nucleic acid assay, a receptor-based assay, and a cytometry assay on said sample.

36 . The method of claim 32 , wherein the device comprises a communication unit configured to perform two-way communication with external devices, further comprising a) receiving instructions regarding one or more of the assays, b) sending data regarding one or more of the assays to an external device, or both a) and b).

37 . The method of claim 34 , wherein the device comprises a communication unit configured to perform two-way communication with external devices, further comprising a) receiving instructions regarding one or more of the assays, b) sending data regarding one or more of the assays to an external device, or both a) and b).

38 . The method of claim 32 , wherein said sample is a biological sample selected from blood, serum, saliva, urine, gastric fluid, digestive fluid, tears, stool, semen, vaginal fluid, interstitial fluid, fluid derived from tumorous tissue, ocular fluid, sweat, mucus, earwax, oil, glandular secretions, breath, spinal fluid, hair, fingernails, skin cells, plasma, fluid obtained from a nasal swab, fluid obtained from a nasopharyngeal wash, cerebrospinal fluid, a tissue sample, fluid or tissue obtained from a throat swab, biopsy tissue, placental fluid, amniotic fluid, cord blood, lymphatic fluids, cavity fluids, sputum, pus, microbiota, meconium, and breast milk.

Assignments (4)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 16, 2018
From: THERANOS, INC.
To: THERANOS IP COMPANY, LLC
Reel/Frame 045075/0310 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 12, 2017
From: THERANOS INC.
To: THERANOS IP COMPANY, LLC
Reel/Frame 044838/0909 →
SECURITY INTEREST Recorded Dec 12, 2017
From: THERANOS IP COMPANY, LLC
To: FORTRESS CREDIT CORP.
Reel/Frame 044839/0568 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 3, 2016
From: HOLMES, ELIZABETH A.; PANGARKAR, CHINMAY; YOUNG, DANIEL
To: THERANOS, INC.
Reel/Frame 038598/0333 →